X0306 4 2022-04-21 0 0001815974 Anebulo Pharmaceuticals, Inc. ANEB 0001770436 English Aron R. C/O ANEBULO PHARMACEUTICALS, INC. 1415 RANCH ROAD 620 SOUTH, SUITE 201 LAKEWAY TX 78734 1 0 1 0 0001640809 22NW Fund, LP 1455 NW LEARY WAY, SUITE 400 SEATTLE WA 98107 0 0 1 0 Common Stock 2022-09-28 4 A 0 1703577 2.81 A 5066290 I 22NW Fund, LP Common Stock 4654528 I Pharma Investors, LLC Stock Option (right to buy) 6.00 2022-04-21 4 A 0 30425 0.00 A 2027-02-28 Common Stock 30425 30425 D Common Stock Purchase Warrant (right to buy) 4.215 2022-09-28 4 A 0 1703577 0.125 A 2022-09-28 2027-09-28 Common Stock 1703577 1703577 D This Form 4 is filed jointly by Aron R. English and 22NW Fund, LP (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. Securities owned directly by 22NW Fund, LP. Mr. English, as the Manager of 22NW Fund GP, LLC, which is the General Partner of 22NW Fund, LP, may be deemed to beneficially own the securities owned directly by 22NW Fund, LP. Securities owned directly by Pharma Investors, LLC. Mr. English, as the owner of Pharma Investors, LLC, may be deemed to beneficially own the securities owned directly by Pharma Investors, LLC. 25% of the option vests on March 1, 2023. Thereafter, 1/48 of the option vests on a monthly basis over 36 months until the option becomes fully vested. /s/ Aron R. English 2022-09-30 22NW Fund, LP; By: 22 NW Fund GP, LLC; By: /s/ Aron R. English 2022-09-30